ConductScience.org, home

Paper23640554

Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Sharma SK and 1 other. Indian J Med Res, 2013. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Papers, record 23640554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23640554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.
PubMed
Journal
Indian J Med Res
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2023-11-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharma SKSurendra K
2Mohan AAlladi

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
HIV InfectionsMajor topic
Tuberculosis, Multidrug-ResistantMajor topic
Coinfection
Humans
India

References211

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121141335Tuberculosis associated immune reconstitution inflammatory syndrome.Indian J Tuberc2010https://conductscience.org/library/papers/21141335PubMed
222191447Current developments and future perspectives for TB diagnostics.Future Microbiol2012https://conductscience.org/library/papers/22191447PubMed
317021358An official ATS statement: hepatotoxicity of antituberculosis therapy.Am J Respir Crit Care Med2006https://conductscience.org/library/papers/17021358PubMed
421392441Tuberculosis among health care workers.Emerg Infect Dis2011https://conductscience.org/library/papers/21392441PubMed
58309034Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.JAMA1994https://conductscience.org/library/papers/8309034PubMed
623391465Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.Lancet2013https://conductscience.org/library/papers/23391465PubMed
71486980A patient with back pain and fever.Eur Respir J1992https://conductscience.org/library/papers/1486980PubMed
88317433Tuberculosis of the gastrointestinal tract and peritoneum.Am J Gastroenterol1993https://conductscience.org/library/papers/8317433PubMed
919287059Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity.Indian J Med Res2009https://conductscience.org/library/papers/19287059PubMed
104572586Pulmonary tuberculosis: evolution of modern therapy.Bull N Y Acad Med1973https://conductscience.org/library/papers/4572586PubMed
1122948580Relevance of latent TB infection in areas of high TB prevalence.Chest2012https://conductscience.org/library/papers/22948580PubMed
1222283888Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India.Int J Tuberc Lung Dis2011https://conductscience.org/library/papers/22283888PubMed
1319886382HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.J Indian Med Assoc2009https://conductscience.org/library/papers/19886382PubMed
141292709HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.Tuber Lung Dis1992https://conductscience.org/library/papers/1292709PubMed
1520209106Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.PLoS One2010https://conductscience.org/library/papers/20209106PubMed
1622719795New drugs to treat tuberculosis.F1000 Med Rep2012https://conductscience.org/library/papers/22719795PubMed
1719671589Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.J Antimicrob Chemother2009https://conductscience.org/library/papers/19671589PubMed
1821740675Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea.Int J Tuberc Lung Dis2011https://conductscience.org/library/papers/21740675PubMed
197812542Accelerated course of human immunodeficiency virus infection after tuberculosis.Am J Respir Crit Care Med1995https://conductscience.org/library/papers/7812542PubMed
207610237Radiologic manifestations of pulmonary tuberculosis.Radiol Clin North Am1995https://conductscience.org/library/papers/7610237PubMed

See all 211 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42801367A review of tigecycline resistance in nontuberculous mycobacteria.Mol Biol Rep2026https://conductscience.org/library/papers/42801367PubMed
42713054Association of Vitamin D Receptor Gene Polymorphism (FokI) with Susceptibility to Musculoskeletal Tuberculosis: A Case-Control Study from Central India.J Orthop Case Rep2026https://conductscience.org/library/papers/42713054PubMed
41464216A Lightweight Hybrid Deep Learning Model for Tuberculosis Detection from Chest X-Rays.Diagnostics (Basel)2025https://conductscience.org/library/papers/41464216PubMed
40208379Evaluation of cytomorphological examination in the diagnosis of pleural effusion.Clin Exp Med2025https://conductscience.org/library/papers/40208379PubMed
39311013Response to treatment and low serum vitamin D levels in North Indian patients with treatment-naive category I and multi-drug resistant pulmonary tuberculosis.Ann Med2024https://conductscience.org/library/papers/39311013PubMed
38025114Deep learning-based analysis of COVID-19 X-ray images: Incorporating clinical significance and assessing misinterpretation.Digit Health2023https://conductscience.org/library/papers/38025114PubMed
38021489Trends of Private Drugs' Sales and Costs Incurred by Patients on Anti-tuberculosis Drugs in Selected Districts of Jharkhand (2022): Results From Sub-national TB-Free Certification.Cureus2023https://conductscience.org/library/papers/38021489PubMed
37808172Early detection of tuberculosis using hybrid feature descriptors and deep learning network.Pol J Radiol2023https://conductscience.org/library/papers/37808172PubMed
37795071Exploring the Esoteric: Tuberculosis of the Medial Epicondyle of the Humerus.Cureus2023https://conductscience.org/library/papers/37795071PubMed
36819973Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now.Cureus2023https://conductscience.org/library/papers/36819973PubMed
36106202Tuberculosis-Associated Anemia: A Narrative Review.Cureus2022https://conductscience.org/library/papers/36106202PubMed
34868509A Novel and Robust Approach to Detect Tuberculosis Using Transfer Learning.J Healthc Eng2021https://conductscience.org/library/papers/34868509PubMed
31723681Miliary tuberculosis: A new look at an old foe.J Clin Tuberc Other Mycobact Dis2016https://conductscience.org/library/papers/31723681PubMed
30983714An Outcome-Based Follow-up Study of Cured Category I Pulmonary Tuberculosis Adult Cases from Various Tuberculosis Units under Revised National Tuberculosis Control Program from a Western Indian City.Indian J Community Med2019https://conductscience.org/library/papers/30983714PubMed
30881619Quinolone-isoniazid hybrids: synthesis and preliminary in vitro cytotoxicity and anti-tuberculosis evaluation.Medchemcomm2019https://conductscience.org/library/papers/30881619PubMed
29688365AntiTbPdb: a knowledgebase of anti-tubercular peptides.Database (Oxford)2018https://conductscience.org/library/papers/29688365PubMed
29664037Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB Programme conditions at a tertiary care teaching hospital in Tirupati, south India.Indian J Med Res2017https://conductscience.org/library/papers/29664037PubMed
29282012Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.BMC Infect Dis2017https://conductscience.org/library/papers/29282012PubMed
28761522Outcome and management of spinal tuberculosis according to severity at a tertiary referral center.Asian J Neurosurg2017https://conductscience.org/library/papers/28761522PubMed
28281441Miliary Tuberculosis.Microbiol Spectr2017https://conductscience.org/library/papers/28281441PubMed

See all 28 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23640554

GET https://conductscience.org/api/papers/v1/23640554/references?page=2